DBV Technologies Reports Q1 2021 Financial Results May 03, 2021 01:30 ET | Source: DBV Technologies S.A. DBV Technologies S.A. DBV Technologies Financial Results DBV Technologies S.A. (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the first quarter of 2021. The quarterly financial statements were approved by the Board of Directors on April 30, 2021. “ through the first quarter of 2021,” said Daniel Tasse, Chief Executive Officer, DBV Technologies. “ We remain diligent about our spend and confident that our cash on hand as of March 31, 2021 will support our operations until the second half of 2022. We continue to focus our attention on advancing